Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Presta

Showing results (21-30 of 184) with videos related to

Pageof 19
Sort By:
Journal of Cellular and Molecular Medicine|September 1, 2007
Role of the soluble pattern recognition receptor PTX3 in vascular biologyMarco Presta, Maura Camozzi, Giovanni Salvatori, et al.
Current Pharmaceutical Design|July 20, 2005
Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discoveryMarco Rusnati, Pasqua Oreste, Giorgio Zoppetti, et al.
International Journal of Molecular Sciences|March 13, 2024
Proteomic Analysis Highlights the Impact of the Sphingolipid Metabolizing Enzyme β-Galactosylceramidase on Mitochondrial Plasticity in Human MelanomaDavide Capoferri, Luca Mignani, Marcello Manfredi, et al.
Journal of Cellular and Molecular Medicine|May 20, 2026
Gremlin-1 Drives Tumour Vascularization by Promoting Endothelial Differentiation and AngiogenesisStefania Mitola, Roberto Ronca, Marco Presta, et al.
Frontiers in Immunology|October 24, 2018
Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2Marco Presta, Eleonora Foglio, Ander Churruca Schuind, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 28, 2017
Long pentraxin 3: A novel multifaceted player in cancerArianna Giacomini, Gaia Cristina Ghedini, Marco Presta, et al.
Expert Review of Anticancer Therapy|June 26, 2018
Future applications of FGF/FGFR inhibitors in cancerGaia Cristina Ghedini, Roberto Ronca, Marco Presta, et al.
Biochimica Et Biophysica Acta|January 30, 2013
Zebrafish embryo as a tool to study tumor/endothelial cell cross-talkChiara Tobia, Giuseppina Gariano, Giulia De Sena, et al.
European Cytokine Network|June 23, 2009
Inflammatory cells and chemokines sustain FGF2-induced angiogenesisMarco Presta, Germán Andrés, Daria Leali, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of ActionMarco Rusnati, Chiara Urbinati, Silvia Bonifacio, et al.
Pageof 19

Showing results (21-30 of 184) with videos related to

Sort By:
Pageof 19
Journal of Cellular and Molecular Medicine|September 1, 2007
Role of the soluble pattern recognition receptor PTX3 in vascular biologyMarco Presta, Maura Camozzi, Giovanni Salvatori, et al.
Current Pharmaceutical Design|July 20, 2005
Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discoveryMarco Rusnati, Pasqua Oreste, Giorgio Zoppetti, et al.
International Journal of Molecular Sciences|March 13, 2024
Proteomic Analysis Highlights the Impact of the Sphingolipid Metabolizing Enzyme β-Galactosylceramidase on Mitochondrial Plasticity in Human MelanomaDavide Capoferri, Luca Mignani, Marcello Manfredi, et al.
Journal of Cellular and Molecular Medicine|May 20, 2026
Gremlin-1 Drives Tumour Vascularization by Promoting Endothelial Differentiation and AngiogenesisStefania Mitola, Roberto Ronca, Marco Presta, et al.
Frontiers in Immunology|October 24, 2018
Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2Marco Presta, Eleonora Foglio, Ander Churruca Schuind, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 28, 2017
Long pentraxin 3: A novel multifaceted player in cancerArianna Giacomini, Gaia Cristina Ghedini, Marco Presta, et al.
Expert Review of Anticancer Therapy|June 26, 2018
Future applications of FGF/FGFR inhibitors in cancerGaia Cristina Ghedini, Roberto Ronca, Marco Presta, et al.
Biochimica Et Biophysica Acta|January 30, 2013
Zebrafish embryo as a tool to study tumor/endothelial cell cross-talkChiara Tobia, Giuseppina Gariano, Giulia De Sena, et al.
European Cytokine Network|June 23, 2009
Inflammatory cells and chemokines sustain FGF2-induced angiogenesisMarco Presta, Germán Andrés, Daria Leali, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of ActionMarco Rusnati, Chiara Urbinati, Silvia Bonifacio, et al.
Pageof 19